Metrics raised 1
- CMCD molecule pipeline target raised to ~50 molecules (from 40+ previously)
Event Participants
Executives
4 S. Ganeshkumar (MD), A. R. Balaji (CFO), Krishna Kumar Rangachari (Business Head - CMCD), N. Muralidharan (Executive Director Finance & SGA)
Analysts
9 Ankur Periwal (Axis Capital), Dharma Teja (Teja Investment), Kiran Gadge (Knightstone Capital Management), Rajakumar Vaidyanathan (RK Investments), Rashmi Gohil (Arihant Capital), Riya Mehta (Aequitas), Rohit Nagraj (360 ONE Capital), Sajal Kapoor (Antifragile Thinking), Sanjesh Jain (ICICI Securities)
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Consolidated Revenue | ₹1,125 crores | Vs ₹1,100 crores in Q1 FY26, +2.3% YoY; impacted by negative PVC spreads and higher input costs |
| EBITDA | -₹115 crores | Sharp input cost increase, high-cost VCM inventory (~$1,000+/ton) booked in Q1 severely compressed margins |
| Net Profit / Loss | -₹176 crores | Net loss on account of EBITDA loss and interest costs |
| Specialty Segment Revenue | ₹427 crores | 38% of consolidated revenue; volumes +21% YoY, driven by CMCD ramp-up |
| Value-Added Chemicals Revenue | ₹129 crores | Vs ₹138 crores YoY (-6.5%); caustic/chloromethane pricing pressure, EDC fire impact |
| Suspension PVC Revenue | ₹569 crores | Vs ₹608 crores YoY (-6.4%); 51% of revenue; negative PVC-VCM spread in Q1 |
| Standalone Revenue | ₹592 crores | Paste PVC, VAM, CMCD businesses; positive EBITDA of ₹7 crores |
| PVC-VCM Spread (Replacement) | ~$160/ton | Current replacement spread; Q1 was negative due to high-cost inventory; EBITDA neutral at $120-130/ton |
| Paste-Suspension Spread | ~$200/ton | Persistent positive differential; supported standalone profitability |
| VCM Price (Delivered, Current) | ~$700/ton | Vs ~$1,000+ in Q1; softening as Middle East feedstock issues resolved |
| Caustic Soda Capacity | 100,000-120,000 tonnes | Operating range; membrane changeover planned causing temporary production loss |
| CMCD Molecule Pipeline | ~50 molecules | 14 commercialized; multiple ramp-ups ongoing |
Geographic & Segment Commentary
Specialty Chemicals (CMCD + Paste PVC + Refrigerants): CMCD delivered a much-improved quarter with healthy order book, 14 commercialized molecules and ~50 in pipeline; MPB 3 Phase 3 and Pilot Phase 3 commissioned. Paste PVC demand recovered in June as downstream rates improved to 70-80%; 7,000-ton debottlenecking at Cuddalore on track for October 2026 commissioning. R32 commercial production commenced May 2026 from swing plant; new plant commissioning underway with full capacity expected by end of fiscal.
Value-Added Chemicals (Caustic Soda, Chloromethanes, H2O2, EDC): Caustic and chloromethane pricing remained under pressure from weak regional demand and oversupply. Chloromethane volumes softer; hydrogen peroxide volumes improved sequentially. On July 17, a fire incident at the Karaikal EDC plant caused manual shutdown - no injuries or spillage; restoration ongoing with authorities.
Suspension PVC: Q1 marked by significant volatility - Middle East conflict disrupted feedstock, customs duty was waived April-June leading to higher Chinese imports. Reinstatement of duty and minimum import price (MIP) expected to support pricing. High-cost VCM inventory carried through July and part of August; replacement spread of ~$160/ton expected from September.
Company-Specific & Strategic Commentary
Anti-Dumping & Trade Defence: Ministry of Finance allowed paste PVC ADD to lapse; company filed writ of mandamus in Madras High Court and obtained favorable order for provisional assessment and bonds to enable retrospective ADD recovery if imposed. Industry working on fresh ADD data for suspension PVC.
Strategic Committee Review: Committee of three independent directors evaluating strategic priorities to enhance long-term valuation; advisors engaged; no definitive outcome yet, update expected when concrete developments occur.
CMCD Global Expansion: Business development head appointed for Europe, representative appointed in Japan; resources already on ground. Diversification beyond agrochemicals into pharma and specialty end-markets progressing with projects at development stage.
Refrigerant Gas R32: Full capacity (14,000 tonnes) online by end of fiscal; go-to-market strategy covers both domestic and international markets with partnership discussions underway; company likely to shift permanently to R32 given global demand trend.
Capacity Expansion: Paste PVC debottlenecking (+7,000 tons) commissioning October 2026; membrane changeover at caustic completed to improve productivity.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| EBITDA | Positive from Q3 FY27 | High-cost VCM inventory washed out by August; replacement spread of ~$160/ton from September. Management expects "reasonable performance" from Q3 |
| EBITDA Breakeven Spread | ~$120-130/ton | Current suspension PVC replacement spread supports this; PBT breakeven needs another $20-30/ton |
| CMCD Revenue | ₹1,000 crores target on track | Existing commercialized molecules' ramp-up driving growth; new BD efforts not factored into target |
| R32 Capacity | Full 14,000-ton capacity by end of FY27 | Plants partially operational; full commissioning this fiscal, with ramp-up through Q4 FY27 to Q1 FY28 |
| Paste PVC Debottlenecking | +7,000 tons by October 2026 | Commissioning on track; strengthens competitive position given $200/ton paste-suspension premium |
| Onerous Contract Provision | ~₹90 crores (Chlorination) + ~₹30 crores (Chemplast) to be reversed in Q2 | Current quarter reversal expected as high-cost inventory flows through |
Risks & Constraints
| Risk | Context |
|---|---|
| EDC Plant Fire (Karaikal) | Fire on July 17 caused manual shutdown of facility. No injuries or spillage. Restoration timeline unclear; operational and revenue impact pending assessment. Company working with authorities on corrective actions. |
| Dumping / Import Pressure | ADD on paste PVC lapsed; customs duty waiver created favorable window for Chinese imports in suspension PVC. MIP and reinstated duty provide only temporary floor - global prices remain the final determinant. Fresh ADD proposals under preparation but timeline uncertain. |
| High-Cost VCM Inventory | Q1 booked VCM at ~$1,000+/ton during supply crisis; will drag margins through July-August. Any renewed Middle East disruption could repeat this scenario given geopolitical volatility. |
| Agrochemical Market Sluggishness | CMCD growth depends on innovator molecule ramp-ups; delayed new molecule launches and Chinese generic competition in agrochemicals could defer volume ramp-ups. Company relying on 14 commercialized molecules and pipeline of ~50 for sustained growth. |
| Balance Sheet Pressure | Annual interest cost ~₹235 crores; four consecutive quarters of losses. Management asserts adequate liquidity (conserved cash + accruals) covers debt servicing and growth capex without external funding, but sustained losses could strain this position. |
| Regulatory Uncertainty | Customs duty and MIP are administrative measures subject to change; trade policy shifts could alter the competitive landscape. High Court order is interim - final ADD decision still pending. |
Q&A Highlights
VCM Sourcing & High-Cost Inventory
- Question: Current VCM sourcing conditions, and whether management would consider partial shutdown given negative spreads? (Rohit Nagraj, 360 ONE)
- Answer: High-cost VCM (~$1,000+/ton) will be consumed by July and part of August. Replacement VCM at ~$700 delivered; PVC at ~$900+, giving ~$160 spread net of taxes. Middle East feedstock issues resolved with plants back to 70-90% capacity; VCM prices expected to soften further. No shutdown contemplated at current spread levels. (S. Ganeshkumar)
ADD & Margins Outlook (Next 1-1.5 Years)
- Question: How to think about margins given ADD did not go through for both PVC products? Any next steps on ADD? (Rohit Nagraj, 360 ONE)
- Answer: Suspension PVC ADD being relooked at with industry data. For paste PVC, the High Court directive (provisional bonds with retrospective duty recovery) is a strong deterrent to low-price dumping. Fresh paste ADD application reviewed on a quarterly basis. Goal is a level playing field, not protection - company claims technical competitiveness with global players at parity pricing. (S. Ganeshkumar)
CMCD ₹1,000 Crore Target & Pipeline
- Question: Is CMCD pickup structural or one-off? Where are we on the ₹1,000 crore target? (Rohit Nagraj, 360 ONE)
- Answer: On track for ₹1,000 crores as previously communicated. Growth reflects ramp-up of molecules commercialized over past few years - expected to continue through coming quarters. (Krishna Kumar Rangachari)
CMCD Pipeline Composition & Commercial Timing
- Question: Earlier guidance was 40+ molecules with 15-17 commercialization this year - any changes? Non-ECM mix? (Ankur Periwal, Axis Capital)
- Answer: Pipeline now ~50 molecules in various development stages; 14 commercialized with more anticipated in coming months. BD resources deployed in Europe and Japan. Pipeline includes pharma and other specialty end-markets beyond Ag-Chem. Near-term revenue will remain predominantly agrochemical-based. (Krishna Kumar Rangachari)
CMCD Utilization & ROCE
- Question: At current utilization (excluding new Phase 3 capacity), what utilization supports targeted ROCE? (Sajal Kapoor, Antifragile Thinking)
- Answer: Utilization ~60-70% on already-commissioned assets - healthy for multipurpose blocks given campaign changeover times. Management indicates contribution margins from new products are scaling toward industry-level returns, expected to reach that this year. (Krishna Kumar Rangachari, S. Ganeshkumar)
Debt Servicing & Liquidity
- Question: With ₹235 crore annual interest cost and negative free cash flow from growth capex, what operating cash flow needed to avoid external funding/dilution? (Sajal Kapoor, Antifragile Thinking)
- Answer: Conserved cash balances and current accruals will cover all debt servicing obligations; sufficient liquidity exists - not a cause for concern. (A. R. Balaji)
PVC-VCM Spread Trajectory (Q2/Q3)
- Question: Are we still carrying high-cost inventory? How to think about Q2/Q3 spreads? (Sanjesh Jain, ICICI Securities)
- Answer: High-cost VCM partially in July and part of August; normal pricing from September. Spread of ~$160 sustaining now. Reinstated customs duty and MIP (6 months) ensure prices won't fall below current levels. This is an India spread. (S. Ganeshkumar)
Paste PVC Spread & Debottlenecking Logic
- Question: What is the paste vs suspension spread? (Sanjesh Jain, ICICI Securities)
- Answer: ~$200/ton differential between paste and suspension - key driver for debottlenecking investment. Better paste PVC realizations supporting standalone P&L. (S. Ganeshkumar)
EBITDA Breakeven Timeline
- Question: With four consecutive loss quarters, what is the line of sight to EBITDA breakeven? (Rashmi Gohil, Arihant Capital)
- Answer: Four positive triggers: (1) Suspension PVC - reinstated duty, MIP, global recovery, lower VCM prices driving ~$160 spread; (2) Paste PVC - customs duty back and High Court bond order driving prices up; (3) CMCD - strong order book for remaining 9 months, 14 molecules in play; (4) Refrigerant gas - full capacity in Q4 FY27. Management sees "strong resilient position" toward turnaround. (S. Ganeshkumar)
R32 Ramp-Up & Commercial Strategy
- Question: Current R32 utilization, full ramp-up timeline, revenue/margin contribution? (Rashmi Gohil, Arihant Capital)
- Answer: Full capacity by end of this fiscal; ramp-up through Q4 FY27 and Q1 FY28. Healthy margin contribution expected though forward-looking guidance withheld. Plant flexibility between R22 and R32 - company expects to move to R32 given global demand shift. (S. Ganeshkumar)
Q1 PVC-VCM Spread & Breakeven Levels
- Question: What was the actual Q1 PVC-VCM spread? What spread needed for EBITDA breakeven? (Kiran Gadge, Knightstone)
- Answer: Q1 spread was negative - average VCM landing ~$1,000+/ton with PVC realization ~$700-750/ton. EBITDA neutral requires ~$120-130/ton; current replacement spread ~$160. High-cost material fully washed out by August. (S. Ganeshkumar, N. Muralidharan)
MIP Impact on Pricing
- Question: With MIP creating a floor, is the incremental PVC price increase passable? (Riya Mehta, Aequitas)
- Answer: MIP currently below market prices - acts as a safety floor, not an upward driver. Ultimately PVC is a globally traded commodity and global prices determine realization. (S. Ganeshkumar)
Onerous Contract Provisions
- Question: Last quarter's provision - full reversal? Any further loss-making contracts? (Rajakumar Vaidyanathan, RK Investments)
- Answer: Entire previous onerous contract provision reversed. New high-cost inventory inflows in current quarter carry a net provision of ~₹90 crores (Chlorination) and ~₹30 crores (Chemplast); these will reverse during Q2. VCM/PVC contracts are market-linked, not fixed-price - high spreads are an anomaly of the war-driven supply crisis, not structural. (A. R. Balaji, S. Ganeshkumar, N. Muralidharan)
FY27 Profitability Timeline
- Question: When does the company turn profitable? (Dharma Teja, Teja Investment)
- Answer: No exact guidance provided. Positive developments - MIP, customs duty reinstated, suspension PVC prices moving up, high-cost inventory washed out. Paste PVC realizations and margins at reasonable levels. CMCD order book strong. "Worst is over" - reasonable performance expected from Q3. (N. Muralidharan)
Pharma CDMO Engagement
- Question: Any pharma client visitations for CDMO business? (Dharma Teja, Teja Investment)
- Answer: Multiple projects ongoing with pharma innovators at development stage; some expected to commercialize later this year or early next financial year. (Krishna Kumar Rangachari)
Key Takeaway
Chemplast Sanmar reported Q1 FY27 consolidated revenue of ₹1,125 crores (+2.3% YoY) with a net loss of ₹176 crores and EBITDA loss of ₹115 crores, driven primarily by high-cost VCM inventory booked at $1,000+/ton during the Middle East supply disruption and negative PVC-VCM spreads. Specialty Chemicals delivered strong momentum - CMCD volumes grew 21% YoY with 14 commercialized molecules (pipeline at ~50), paste PVC realized ~$200/ton premium over suspension, and R32 commercial production commenced. Management's turnaround thesis rests on four triggers: reinstated customs duty and minimum import price on suspension PVC, the Madras High Court bond order deterring paste PVC dumping, a healthy CMCD order book for the remaining nine months, and full R32 capacity by Q4 FY27. With replacement spreads at ~$160/ton versus EBITDA breakeven of $120-130/ton, management expects "reasonable performance" from Q3 FY27 after high-cost inventory washout by August; the strategic committee of independent directors continues evaluating options for long-term valuation enhancement. Key watch points include EDC plant restart timelines post-fire, sustainability of the $160 spread, and execution on CMCD's ₹1,000 crore revenue target.